Lutfiye  Dalkilic Dalkilic

Dr. Lutfiye Dalkilic Dalkilic


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
ÖÇÖnder Çelik
Önder Çelik
AYarzu yurci
arzu yurci
AEAynur Ersahin
Aynur Ersahin
NGNUR DOKUZEYLÜL GÜNGÖR
NUR DOKUZEYLÜL GÜNGÖR
NCNilufer Celik
Nilufer Celik
ANDREA TINELLIANDREA TINELLI
ANDREA TINELLI
Background: Homeobox genes A10 (HOXA10) and A11 (HOXA11), members of the abdominal B gene family, are responsible for embryonic survival and implantation. This study was planned to investigate whether endometrial injury alters the expression of both transcripts in women with implantation failure. Methods: A total of 54 women with implantation failure were divided into two equal groups as experimental (scratching) and sham (no scratching). Participants in the scratching group were exposed to endometrial injury in the mid-luteal phase, and those in the sham group were exposed to endometrial flushing. The scratching group, but not the sham group, underwent prior endometrial sampling. A second endometrial sampling was performed on the scratching group in the mid-luteal phase of the following cycle. The mRNA and protein levels of the HOXA10 and 11 transcripts were determined in endometrial samples collected before and after injury/flushing. Participants in each group underwent IVF/ET in the cycle after the second endometrial sampling. Results: Endometrial injury caused a 60.1-fold (p < 0.01) increase in HOXA10 mRNA and a 9.0-fold increase in HOXA11 mRNA (p < 0.02). Injury resulted in a significant increase in both HOXA10 (p < 0.001) and HOXA11 protein expression (p < 0.003). There was no significant change in HOXA10 and 11 mRNA expressions after flushing. Clinical pregnancy, live birth, and miscarriage rates of the both groups were similar. Conclusions: Endometrial injury increases homeobox transcript expression at both mRNA and protein levels.

1 January 2023 in International Journal of Plant Based Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LDLutfiye Dalkilic Dalkilic
Lutfiye Dalkilic Dalkilic
SDSemih Dalkılıç
Semih Dalkılıç
LULütfü Uygur
Lütfü Uygur
Cancer is one of the most common pathologies in the world, which for centuries has led to a decline in the standard of living and even death of many people. In short, cancer is a disease that occurs when mutations in genes that limit and regulate cell proliferation, survival, and movement are reflected in somatic cells. In recent years, there have been many new and promising developments in the world of science for cancer treatment. However, due to the side effects of some treatments, the cost of others, and the fact that some drugs are still in the trial phase, it has not yet reached the expected level of treatment and success. This has encouraged the scientific community to investigate natural agents due to their lower cost and limited side effects. Juglans regia L., popularly known as walnut, is a plant containing many natural compounds that have been used both as a foodstuff and for various medicinal purposes from past to present. As a result of the literature review, it is known that walnut has many medicinal and biological properties, especially anti-inflammatory, antifungal and antiallergic properties. In this study, the outer shells of J. regia were used and the components of these shells were extracted with three different solvents: methanol, ethanol, and hexane. These extracts were used in cytotoxic activity and antioxidant activity assays. The antioxidant activity of the extract was determined using a DPPH assay. Cytotoxic activity was determined by MTT assay using a breast cancer cell line (MDA-MB-231). J. regia extracts were found to have significant cytotoxic activity on the MDA-MB-231 cell line. It has been observed that the outer bark of J. regia showed more potent anticancer effects than antioxidant activity. According to the results obtained from the study, the antioxidant and cytotoxic effect of the outer bark of J. regia is thought to contribute significantly to the identification of new active substances for cancer treatment. Therefore, further studies are needed to fully determine the effects of the outer bark of J. regia.

16 April 2025 in Life
Verified
Journal Article
Open access
PDF file
SDSemih Dalkilic
Semih Dalkilic
LDLutfiye Dalkilic Dalkilic
Lutfiye Dalkilic Dalkilic
EIElgun İsbenov
Elgun İsbenov
Lütfü UygurLütfü Uygur
Lütfü Uygur
CTCeydanur Taşdemir
Ceydanur Taşdemir
Cancer is a common disease worldwide, and medicinal plants are widely used for its treatment. A. agallocha is a plant from the Thymelaeaceae family that is endemic to East Asia. Popularly known as the agar tree, this plant is used in the treatment of heart diseases, asthma, cough, ulcers, gout, inflammation, and pain. In this study, the cytotoxic, apoptotic/necrotic, and antioxidant activities of root extracts of A. agallocha and their effects on gene expression were investigated. Cytotoxic effects were analyzed by the MTT assay method, apoptotic/necrotic effects by the double staining method, and antioxidant effects by the DPPH radical scavenging assay. According to the results, the best cytotoxic effect in HepG2 cells was observed at 1000 µg/mL hexane extract. In MCF-7 cells, 250 µg/mL hexane extract showed the best activity. Antioxidant activity was highest in dH2O and lowest in the methanol extract. In gene expression analysis, hexane and methanol extracts decreased p53 expression in HepG2 cells, while acetone extract increased it. In addition, the expression of Bax and Bcl-2 genes generally increased. This study revealed the potent cytotoxic, antioxidant, and apoptotic effects of the A. agallocha extract.

27 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GAGülsüm Altuntaş
Gülsüm Altuntaş
AÇAyşe Çapar
Ayşe Çapar
GÖGülsüm Özçelik
Gülsüm Özçelik
EÇErkan Çakmak
Erkan Çakmak
LDLutfiye Dalkilic Dalkilic
Lutfiye Dalkilic Dalkilic
IDİsmail Demirel
İsmail Demirel
Background: Sepsis is a life-threatening condition characterized by a dysregulated host response to infection. Hemadsorption therapies remove inflammatory mediators and are used as adjunctive treatment in selected patients. Although increased immature granulocyte (IG) levels correlate with inflammatory severity, changes in IG levels after hemadsorption therapy have not been previously evaluated. Methods: This retrospective observational study included patients with sepsis who received hemadsorption therapy in intensive care units between January 2021 and July 2025. Sepsis was diagnosed according to the Surviving Sepsis Campaign 2021 guidelines, and hemadsorption was initiated for persistent hemodynamic instability despite standard therapy. Treatment was performed using a Jafron HA330 cartridge for at least three 6 h sessions. IG count and percentage, inflammatory parameters, lactate levels, and organ dysfunction scores were recorded before and after therapy. ICU mortality was the primary outcome. Statistical analyses included paired comparisons, multivariable logistic regression, and ROC curve analysis. Results: Among 887 patients with sepsis, 196 met the inclusion criteria. The ICU mortality rate was 43.9%, and the median time between pre- and post-treatment measurements was 4 days (IQR: 3–5). After hemadsorption therapy, IG count, IG%, inflammatory parameters, lactate levels, SOFA scores, and vasopressor requirements decreased (all p-values < 0.001). IG parameters were higher in non-survivors. Post-treatment IG# (AUC 0.880) and IG% (AUC 0.812) showed good discriminative performance. Conclusions: Hemadsorption therapy was associated with reductions in IG parameters and inflammatory indicators in sepsis. These findings support IG parameters as complementary measures of immune and inflammatory dynamics during hemadsorption therapy. Accordingly, this study should be regarded as a hypothesis-generating investigation describing associations of IG dynamics in septic patients undergoing hemadsorption, rather than demonstrating treatment efficacy or causal effects.